MediXall Group Subsidiary Health Karma Mental Health Awareness Campaign Drives Consumer Acquisition
FORT LAUDERDALE, FL / ACCESSWIRE / May 18, 2021 / MediXall Group, Inc. (OTCQB:MDXL) is pleased to report that its...
Day: May 18, 2021
Jaguar Health Provides Updates on Canalevia (Crofelemer), the First Plant-based Prescription Medicine Under Development for Chemotherapy-induced Diarrhea in Dogs and Exercise-induced Diarrhea in Dogs
Canalevia would be first and only FDA-approved plant-based medicine for dogs that suffer from diarrhea during chemotherapy Canalevia will be...
CLS Holdings USA, Inc. Production Division Sees Continued Category Performance Growth, Increasing Output and Brand Footprint
LAS VEGAS, NV / ACCESSWIRE / May 18, 2021 / CLS Holdings USA, Inc. (OTCQB:CLSH)(CSE:CLSH), the ''Company'' or ''CLS'', a diversified...
Leafbuyer Technologies, Inc. Announces Profitability and Significant Revenue Growth
DENVER, CO / ACCESSWIRE / May 18, 2021 / Leafbuyer Technologies, Inc. "Leafbuyer" or "the Company") (OTCQB:LBUY), a leading CannaTech company, announced...
Novamind Opens Client Care Center to Support High Demand for Treatments
Invests in care support systems to facilitate rapid expansion TORONTO, ON / ACCESSWIRE / May 18, 2021 / Novamind Inc....
9 Meters Biopharma, Inc. to Present at Oppenheimer’s Rare & Orphan Disease Summit
RALEIGH, NC / ACCESSWIRE / May 18, 2021 / 9 Meters Biopharma, Inc. (NASDAQ:NMTR), a clinical-stage company focused on rare...
Obalon Therapeutics Stockholders Special Meeting Adjourned to May 25, 2021
Urging all Shareholders to Vote For Proposals Related to Merger with ReShape LifeSciences Inc. Meeting to be held via Webcast...
Longeveron Announces the Hiring of Dan Gincel, Ph.D., as Senior Vice President, Strategic Collaborations & Scientific Affairs
Will Lead Business Development Activities After 14 Years as Executive Director of Maryland Stem Cell Research FundMIAMI, May 18, 2021...
Notification on convocation of the Joint Stock Company “Olainfarm” Extraordinary General Meeting of Shareholders
The Management Board of joint stock company “Olainfarm”, registration number: 40003007246, legal address: Rūpnīcu iela 5, Olaine, LV-2114, Latvia (hereafter...
Icario/Harris Poll Data Finds Nearly a Quarter of Medicaid Members Don’t Have Access to Food Support Programs
Another 20% of Members Say They Aren’t Sure if Their Plan Offers Such ProgramsMINNEAPOLIS, May 18, 2021 (GLOBE NEWSWIRE) --...
Madrigal Pharmaceuticals to Present at RBC Capital Markets Virtual 2021 Global Healthcare Conference on Wednesday, May 19, 2021 at 8:00 a.m. ET
WEST CONSHOHOCKEN, Pa., May 18, 2021 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc (NASDAQ: MDGL), a clinical-stage biopharmaceutical company pursuing novel...
Digipath Announces Results for Second Fiscal Quarter 2021
Achieves First Profitable Quarter in Its History and Sees Significant Revenue Growth, Compared to the First Fiscal Quarter LAS VEGAS,...
National Research Corporation Expands Board Strength with Appointments of Healthcare Industry Veterans
Allina Health CEO Penny Wheeler and Former Sutter Health Chief Medical Officer Stephen Lockhart Add Their Deep Innovation and Vision...
Amedisys Named to Modern Healthcare’s “Best Places to Work in Healthcare”
BATON ROUGE, La., May 18, 2021 (GLOBE NEWSWIRE) -- Modern Healthcare recently named Amedisys, Inc., one of the nation’s leading...
Rafarma’s Global Pharmaceutical Strategy At A Glance
Nicosia, Cyprus, May 18, 2021 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. OTC:(RAFA) is an international biotechnological and pharmaceutical company that...
Sarepta Therapeutics’ Investigational Gene Therapy for the Treatment of Duchenne Muscular Dystrophy, SRP-9001, Demonstrates Robust Expression and Consistent Safety Profile Using Sarepta’s Commercial Process Material
Results from the first 11 participants enrolled in Study 9001-103 ENDEAVOR showed robust transduction, delivering mean vector genome copies of...
Combined Apollon and Aion Formulations Kill Breast Cancer Cells Through Multiple Pathways
London, England and Toronto, Ontario--(Newsfile Corp. - May 18, 2021) - Apollon Formularies plc (LSE: APOL) ("Apollon" or the "Company"),...
Model N Spring Release for Life Sciences: Continuous Innovation to Automate and Improve Front- and Back-Office Processes
Leader in Life Sciences Revenue Management Delivers Greater Pricing Accuracy and Timeliness for Increased Competitiveness, While Simplifying the Membership Management...
Axonics® Announces CE Mark Approval for Implantable Sacral Neurostimulator that Significantly Extends Recharge Interval
IRVINE, Calif.--(BUSINESS WIRE)--Axonics, Inc. (Nasdaq: AXNX), a global medical technology company that is developing and commercializing novel products for the...
Model N Spring Release for High Tech: Intelligence, Automation and Insights Enhance the Buying and Selling Journey
Leader in High Tech Revenue Management Provides AI-Powered Insights That Enable Better-Informed Pricing Decisions and Deliver Greater Financial Control SAN...